Российская академия наук


Размер1.98 Mb.
1   ...   262   263   264   265   266   267   268   269   ...   848

Zhygadlo E.Y.1, Bezdudny A.V.2, Gaidai A.V.1, Levandovsky I.A.1

1National University of Ukraine “KPI”, Kyiv, Ukraine. e-mail: lia@xtf.ntu-kpi.kiev.ua"

2Institute of Organic Chemistry National academy of sciences of Ukraine
Nowadays, due to the aging of society, nervous system diseases, such as Alzheimer's, Parkinson's, multiple sclerosis, etc. have become widely spread. These disorders are caused by damages and even death of neurons due to their excessive excitement in consequence of overactivation of NMDA-and AMPA-receptors by neurotransmitters (excitotoxicity).

One of the approaches to the treatment of these diseases is based on inhibition of NMDA-receptors (the drug memantine ), resulting in the suppression of nervous impulses. Transmission of nervous impulses, on the other hand, can be depressed by inhibitory neurotransmitters. Among them are γ-aminobutyric acid (GABA) and glycine. However, GABA itself, due to the low lipophilicity, is poorly transported through the blood-brain barrier, so in medicine they use its structural analogue containing a lipophilic moiety (gabapentin (2-(1-aminocyclohexyl)acetic acid)).

We have proposed to introduce GABA or glycine fragments into compounds containing adamantane skeleton and trifluoromethyl substituent. The proposed structure of the molecules would significantly increase their lipophilicity, and, consequently, penetration through the blood-brain barrier.

The target compounds either structural analogues of GABA (3-amino-5-(trifluoromethyl)adamantane-1-carboxylic acid, 2-(2-amino-5-(trifluoromethyl)adamantan-2-yl)acetic acid), or those of glycine (2-amino-2-(3-(trifluoromethyl)adamantan-1-yl)acetic acid). Currently, we have developed approaches to the synthesis of these compounds and obtained their precursors. It should be noted that the presence of two electron withdrawing groups in the source acid complicates the introduction of the amino group in target compounds.

Каталог: news
news -> Умеренные когнитивные нарушения у больных с сосудистым поражением головного мозга 14. 01. 11 нервные болезни
news -> 15-й международный медицинский форум «качество и безопасность оказания медицинской помощи» нижегородская ярмарка россия, Нижний Новгород
news -> Сборник материалов
news -> Разработка технологии вкусоароматических добавок с применением сенсорных технологий
news -> «казұму 85 жыл: жетістіктері мен келешегі» халықаралық ғылыми-тəжірибелік конференция аясындағы «клиникалық фармация: халықаралық ТƏжірибе мен қазақстанның денсаулық сақтаудағы даму ерекшеліктері»
news -> Программа международной научно-практической конференции 14-15 апреля 2016 г. Курск 2016
news -> Российская академия наук отделение физиологических наук

Поделитесь с Вашими друзьями:
1   ...   262   263   264   265   266   267   268   269   ...   848

База данных защищена авторским правом ©zodorov.ru 2017
обратиться к администрации

    Главная страница